trending Market Intelligence /marketintelligence/en/news-insights/trending/yexupX5wxOMhQkJC5x9ISA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Celldex Therapeutics appoints board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Celldex Therapeutics appoints board member

Celldex Therapeutics Inc. appointed Gerald McMahon to its board of directors.

Board member Richard van den Broek resigned, "due to increasing responsibilities in other endeavors," the company said.

McMahon was previously the president and CEO of Kolltan Pharmaceuticals.

Hampton, N.J.-based Celldex develops therapeutics for the immune system.